RATIONALE: Mast cells have important roles in innate immunity and tissue remodeling but have remained poorly studied in inflammatory airway diseases like chronic obstructive pulmonary disease (COPD). OBJECTIVES: To perform a detailed histological characterization of human lung mast cell populations at different severities of COPD, comparing with smoking and never-smoking control subjects. METHODS: Mast cells were analyzed in lung tissues from patients with mild to very severe COPD, GOLD I-IV (n = 25, 10 of whom were treated with corticosteroids). Never-smokers and smokers served as controls. The density, morphology, and molecular characteristics of mucosal and connective tissue mast cells (MC(T) and MC(TC), respectively) were analyzed in several lung regions. MEASUREMENTS AND MAIN RESULTS: In all compartments of COPD lungs, especially at severe stages, the MC(TC) population increased in density, whereas the MC(T) population decreased. The net result was a reduction in total mast cell density. This phenomenon was paralleled by increased numbers of luminal mast cells, whereas the numbers of terminal transferase dUTP nick end labeling (TUNEL)(+) apoptotic mast cells remained unchanged. In COPD lungs, the MC(T) and MC(TC) populations showed alterations in morphology and expression of CD88 (C5a-R), transforming growth factor (TGF)-beta, and renin. Statistically significant correlations were found between several COPD-related mast cell alterations and lung function parameters. CONCLUSIONS: As COPD progresses to its severe stages, the mast cell populations in the lung undergo changes in density, distribution, and molecular expression. In COPD lungs, these novel histopathological features were found to be correlated to lung function and they may thus have clinical consequences.
RATIONALE: Mast cells have important roles in innate immunity and tissue remodeling but have remained poorly studied in inflammatory airway diseases like chronic obstructive pulmonary disease (COPD). OBJECTIVES: To perform a detailed histological characterization of human lung mast cell populations at different severities of COPD, comparing with smoking and never-smoking control subjects. METHODS: Mast cells were analyzed in lung tissues from patients with mild to very severe COPD, GOLD I-IV (n = 25, 10 of whom were treated with corticosteroids). Never-smokers and smokers served as controls. The density, morphology, and molecular characteristics of mucosal and connective tissue mast cells (MC(T) and MC(TC), respectively) were analyzed in several lung regions. MEASUREMENTS AND MAIN RESULTS: In all compartments of COPD lungs, especially at severe stages, the MC(TC) population increased in density, whereas the MC(T) population decreased. The net result was a reduction in total mast cell density. This phenomenon was paralleled by increased numbers of luminal mast cells, whereas the numbers of terminal transferase dUTP nick end labeling (TUNEL)(+) apoptotic mast cells remained unchanged. In COPD lungs, the MC(T) and MC(TC) populations showed alterations in morphology and expression of CD88 (C5a-R), transforming growth factor (TGF)-beta, and renin. Statistically significant correlations were found between several COPD-related mast cell alterations and lung function parameters. CONCLUSIONS: As COPD progresses to its severe stages, the mast cell populations in the lung undergo changes in density, distribution, and molecular expression. In COPD lungs, these novel histopathological features were found to be correlated to lung function and they may thus have clinical consequences.
Authors: Soumyaroop Bhattacharya; Diana Go; Daria L Krenitsky; Heidi L Huyck; Siva Kumar Solleti; Valerie A Lunger; Leon Metlay; Sorachai Srisuma; Susan E Wert; Thomas J Mariani; Gloria S Pryhuber Journal: Am J Respir Crit Care Med Date: 2012-06-21 Impact factor: 21.405
Authors: Seung-Ick Cha; Christine S Chang; Eun Kyung Kim; Jae W Lee; Michael A Matthay; Jeffrey A Golden; Brett M Elicker; Kirk Jones; Harold R Collard; Paul J Wolters Journal: Histopathology Date: 2012-03-06 Impact factor: 5.087
Authors: Silvana Balzar; Merritt L Fajt; Suzy A A Comhair; Serpil C Erzurum; Eugene Bleecker; William W Busse; Mario Castro; Benjamin Gaston; Elliot Israel; Lawrence B Schwartz; Douglas Curran-Everett; Charity G Moore; Sally E Wenzel Journal: Am J Respir Crit Care Med Date: 2010-09-02 Impact factor: 21.405
Authors: Jie Zhu; Venkata Bandi; Shengyang Qiu; David J Figueroa; Jilly F Evans; Neil Barnes; Kay K Guntupalli; Peter K Jeffery Journal: Chest Date: 2012-08 Impact factor: 9.410
Authors: Emma L Beckett; Richard L Stevens; Andrew G Jarnicki; Richard Y Kim; Irwan Hanish; Nicole G Hansbro; Andrew Deane; Simon Keely; Jay C Horvat; Ming Yang; Brian G Oliver; Nico van Rooijen; Mark D Inman; Roberto Adachi; Roy J Soberman; Sahar Hamadi; Peter A Wark; Paul S Foster; Philip M Hansbro Journal: J Allergy Clin Immunol Date: 2013-02-04 Impact factor: 10.793
Authors: Michael H Cho; Merry-Lynn N McDonald; Xiaobo Zhou; Manuel Mattheisen; Peter J Castaldi; Craig P Hersh; Dawn L Demeo; Jody S Sylvia; John Ziniti; Nan M Laird; Christoph Lange; Augusto A Litonjua; David Sparrow; Richard Casaburi; R Graham Barr; Elizabeth A Regan; Barry J Make; John E Hokanson; Sharon Lutz; Tanda Murray Dudenkov; Homayoon Farzadegan; Jacqueline B Hetmanski; Ruth Tal-Singer; David A Lomas; Per Bakke; Amund Gulsvik; James D Crapo; Edwin K Silverman; Terri H Beaty Journal: Lancet Respir Med Date: 2014-02-07 Impact factor: 30.700